We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

7 hedge funds and large institutions have $695K invested in China Pharma Holdings in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more ownership

Funds ownership: 0% → 0.01% (+0%)

12% less capital invested

Capital invested by funds: $789K → $695K (-$94K)

13% less funds holding

Funds holding: 8 → 7 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$151K
2
HF
HRT Financial
New York
+$15.6K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$9.95K
4
UBS Group
UBS Group
Switzerland
+$2.84K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$33K
2
Millennium Management
Millennium Management
New York
-$21K
3
VF
Virtu Financial
New York
-$18.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$391K +$151K +426 +44%
HF
2
HRT Financial
New York
$158K +$15.6K +44 +8%
BCM
3
Bridgeway Capital Management
Texas
$109K – – –
VF
4
Virtu Financial
New York
$18K -$18.1K -51 -44%
UBS Group
5
UBS Group
Switzerland
$11K +$2.84K +8 +26%
Two Sigma Advisers
6
Two Sigma Advisers
New York
$8K +$9.95K +28 New
Citadel Advisors
7
Citadel Advisors
Florida
– -$33K -92 Closed
Millennium Management
8
Millennium Management
New York
– -$21K -58 Closed

CPHI Hedge Fund Activity: Q3 2021 in Review

7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2021, worth a combined $695K — down 12% from $789K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CPHI and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $151K. The largest seller was Citadel Advisors, exiting entirely with an estimated $33K sold.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q3 2021, down from 8 in Q2 2021.
  • Funds reported $695K of China Pharma Holdings stock for Q3 2021, down 12% quarter-over-quarter.
  • 1 fund opened new China Pharma Holdings positions in Q3 2021 and 2 closed out, a net change of -1 holder.
  • The largest China Pharma Holdings buyer in Q3 2021 was Renaissance Technologies, an estimated $151K added.
  • The largest China Pharma Holdings seller in Q3 2021 was Citadel Advisors, an estimated $33K sold.

Based on aggregated 13F filings for Q3 2021.